Market Research Logo

Europe Market Report for Surgical Robotics Systems 2017 - MedCore

EXECUTIVE SUMMARY
EUROPEAN ROBOTICS AND SURGICAL NAVIGATION MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES COVERED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 MEDICAL CONDITIONS
2.1.1 Neurosurgery Conditions
2.1.1.1 Hydrocephalus
2.1.1.2 Communicating Hydrocephalus
2.1.1.3 Normal Pressure Hydrocephalus
2.1.1.4 Non-Communicating Hydrocephalus
2.1.1.5 Brain Tumor
2.1.1.6 Intracranial Pressure
2.1.1.7 Intracranial Aneurysm
2.1.1.8 Intracranial Atherosclerosis Disease
2.1.2 Spinal Conditions
2.1.2.1 Herniated Disc
2.1.2.2 Spinal Stenosis
2.1.2.3 Spondylosis
2.1.2.4 Scoliosis
2.1.2.5 Lordosis
2.1.2.6 Kyphosis
2.1.3 ENT Conditions
2.1.3.1 Otitis Media
2.1.3.2 Cholesteatomas
2.1.3.3 Otosclerosis
2.1.3.4 Chronic Sinusitis
2.1.3.5 Tonsillitis
2.1.4 Orthopedic Conditions
2.1.4.1 Fractures
2.1.4.2 Osteoporosis
2.1.4.3 Arthritis
2.1.5 Gynecological Conditions
2.1.5.1 Gynecological Cancers
2.1.5.2 Uterine Fibroids
2.1.5.3 Endometriosis
2.1.5.4 Menorrhagia
2.1.5.5 Pelvic Prolapse
2.1.6 Urological Conditions
2.1.6.1 Prostate Cancer
2.1.6.2 Bladder Cancer
2.1.6.3 Kidney Cancer
2.1.6.4 Benign Prostate Hyperplasia (BPH)
2.1.7 Digestive Tract Conditions
2.1.7.1 Achalasia
2.1.7.2 Stomach Cancer
2.1.7.3 Hernia
2.1.7.4 Gallbladder Attack
2.1.7.5 Gastroesophageal Reflex Disease
2.1.8 Colorectal Conditions
2.1.8.1 Colorectal Cancer
2.1.8.2 Inflammatory Bowel Disease
2.1.8.3 Diverticulitis
2.1.9 Cardiac Conditions
2.1.9.1 Mitral Valve Prolapse
2.1.9.2 Coronary Artery Disease
PRODUCT ASSESSMENT
3.1 ROBOTIC ASSISTED SURGERY PRODUCT PORTFOLIOS
3.1.1 Robotic-Assisted Surgery Overview
3.1.2 Neurosurgery
3.1.3 Spine Surgery
3.1.4 Orthopedic Surgery
3.1.5 Minimally Invasive Surgery
3.1.6 Radiosurgery
3.1.7 Catheter Placement
3.2 RAS REGULATORY ISSUES AND RECALLS
3.2.1 Accuray Inc.
3.2.2 Blue Belt Technologies
3.2.3 Hansen Medical Inc.
3.2.4 Intuitive Surgical
3.2.5 MAKO Surgical/Stryker
3.2.6 OMNIlife Science
3.3 CLINICAL TRIALS
3.4 RAS CLINICAL TRIALS
3.4.1 Accuray Inc.
3.4.2 Catheter Precision
3.4.3 Corindus Inc
3.4.4 Hansen Medical
3.4.5 Intuitive Surgical
3.4.6 MAKO Surgical/Stryker
3.4.7 Mazor
3.4.8 Medrobotics
3.4.9 Medtech
SURGICAL ROBOTICS MARKET
4.1 INTRODUCTION
4.2 SPINE ROBOTIC ASSISTED SURGERY SYSTEM MARKET
4.2.1 Introduction
4.2.2 Market Analysis and Forecast
4.2.3 Drivers and Limiters
4.2.3.1 Market Drivers
4.2.3.2 Market Limiters
4.2.4 Leading Competitors
4.2.5 Emerging Competitors
4.3 NEUROSURGERY ROBOTIC ASSISTED SURGERY SYSTEM MARKET
4.3.1 Introduction
4.3.2 Market Analysis and Forecast
4.3.3 Drivers and Limiters
4.3.3.1 Market Drivers
4.3.3.2 Market Limiters
4.3.4 Leading Competitors
4.3.5 Emerging Competitors
4.4 MINIMALLY INVASIVE SURGERY ROBOTIC DEVICE MARKET
4.4.1 Introduction
4.4.2 Market Analysis and Forecast
4.4.3 Drivers and Limiters
4.4.3.1 Market Drivers
4.4.3.2 Market Limiters
4.4.4 Leading Competitors
4.4.5 Emerging Competitors
4.5 ROBOTIC RADIOSURGERY DEVICE MARKET
4.5.1 Introduction
4.5.2 Market Analysis and Forecast
4.5.3 Drivers and Limiters
4.5.3.1 Market Drivers
4.5.3.2 Market Limiters
4.5.4 Leading Competitors
4.6 ROBOTIC CATHETER SYSTEM MARKET
4.6.1 Introduction
4.6.2 Market Analysis and Forecast
4.6.3 Drivers and Limiters
4.6.3.1 Market Drivers
4.6.3.2 Market Limiters
4.6.4 Leading Competitors
4.7 ROBOTIC ASSISTED ORTHOPEDIC SURGERY MARKET
4.7.1 Introduction
4.7.2 Market Analysis and Forecast
4.7.3 Drivers and Limiters
4.7.3.1 Market Drivers
4.7.3.2 Market Limiters
4.7.4 Leading Competitors
ABBREVIATIONS
APPENDIX: COMPETITOR PRESS RELEASES
List of Charts
Chart 1 1: Surgical Navigation System Market by Segment, Europe, 2013 – 2023
Chart 1 2: Robotic Assisted Surgery Market by Segment, Europe, 2013 – 2023
Chart 1 3: Robotics and Surgical Navigation Market Overview, Europe, 2016 & 2023
Chart 4 1: Spine Robotic Assisted Surgery System Market, Europe, 2013 – 2023
Chart 4 2: Leading Competitors, Spine Robotic Assisted Surgery System Market, Europe, 2016
Chart 4 3: Neurosurgery Robotic Assisted Surgery System Market, Europe, 2013 – 2023
Chart 4 4: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
Chart 4 5 Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023
Chart 4 6: Leading Competitors, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
Chart 4 7 Robotic Radiosurgery Device Market, Europe, 2013 – 2023
Chart 4 8: Robotic Catheter System Market, Europe, 2013 – 2023
Chart 4 9: Leading Competitors by Country, Robotic Catheter System Market, Europe, 2016
Chart 4 10: Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023
Chart 4 11: Leading Competitors by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2016
List of Figures
Figure 1 1: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, Europe
Figure 1 5: Recent Events in the Robotics and Surgical Navigation Market, Europe, 2012 – 2016
Figure 1 6: Robotics and Surgical Navigation Procedures Covered, Europe, 2016
Figure 1 7: Robotics and Surgical Navigation Markets Covered, Europe, 2016 (1 of 2)
Figure 1 8: Robotics and Surgical Navigation Markets Covered, Europe, 2016 (2 of 2)
Figure 1 9: Key Report Updates
Figure 1 10: Version History
Figure 3 1: Robot-Assisted Neurosurgery Products by Company
Figure 3 2: Robot-Assisted Spine Surgery Products by Company
Figure 3 3: Robot-Assisted Orthopedic Surgery Products by Company
Figure 3 4: Robot-Assisted Radiosurgery Products by Company
Figure 3 5: Robot-Assisted Catheter Placement Products by Company
Figure 3 6: Class 2 Device Recall Accuray Inc
Figure 3 7: Class 2 Device Recall Accuray Inc
Figure 3 8: Class 2 Device Recall Accuray Inc
Figure 3 9: Class 2 Device Recall Accuray Inc
Figure 3 10: Class 2 Device Recall Accuray Inc
Figure 3 11: Class 2 Device Recall Accuray Inc
Figure 3 12: Class 2 Device Recall Blue Belt Technologies
Figure 3 13: Class 2 Device Recall Blue Belt Technologies
Figure 3 14: Class 2 Device Recall Blue Belt Technologies
Figure 3 15: Class 2 Device Recall Hansen Medical
Figure 3 16: Class 2 Device Recall Hansen Medical
Figure 3 17: Class 2 Device Recall Hansen Medical
Figure 3 18: Class 2 Device Recall Intuitive Surgical
Figure 3 19: Class 2 Device Recall Intuitive Surgical
Figure 3 20: Class 2 Device Recall Intuitive Surgical
Figure 3 21: Class 2 Device Recall Intuitive Surgical
Figure 3 22: Class 2 Device Recall Intuitive Surgical
Figure 3 23: Class 2 Device Recall Intuitive Surgical
Figure 3 24: Class 2 Device Recall Intuitive Surgical
Figure 3 25: Class 2 Device Recall Intuitive Surgical
Figure 3 26: Class 2 Device Recall Intuitive Surgical
Figure 3 27: Class 2 Device Recall Intuitive Surgical
Figure 3 28: Class 2 Device Recall Intuitive Surgical
Figure 3 29: Class 2 Device Recall Intuitive Surgical
Figure 3 30: Class 2 Device Recall Intuitive Surgical
Figure 3 31: Class 2 Device Recall Intuitive Surgical
Figure 3 32: Class 2 Device Recall Intuitive Surgical
Figure 3 33: Class 2 Device Recall Intuitive Surgical
Figure 3 34: Class 2 Device Recall Intuitive Surgical
Figure 3 35: Class 2 Device Recall Intuitive Surgical
Figure 3 36: Class 2 Device Recall Intuitive Surgical
Figure 3 37: Class 2 Device Recall Intuitive Surgical
Figure 3 38: Class 2 Device Recall Intuitive Surgical
Figure 3 39: Class 2 Device Recall Intuitive Surgical
Figure 3 40: Class 2 Device Recall Intuitive Surgical
Figure 3 41: Class 2 Device Recall Intuitive Surgical
Figure 3 42: Class 2 Device Recall Intuitive Surgical
Figure 3 43: Class 2 Device Recall Intuitive Surgical
Figure 3 44: Class 2 Device Recall Intuitive Surgical
Figure 3 45: Class 2 Device Recall Intuitive Surgical
Figure 3 46: Class 2 Device Recall Intuitive Surgical
Figure 3 47: Class 2 Device Recall Intuitive Surgical
Figure 3 48: Class 2 Device Recall Intuitive Surgical
Figure 3 49: Class 2 Device Recall Intuitive Surgical
Figure 3 50: Class 2 Device Recall Intuitive Surgical
Figure 3 51: Class 2 Device Recall Intuitive Surgical
Figure 3 52: Class 2 Device Recall Intuitive Surgical
Figure 3 53: Class 2 Device Recall Intuitive Surgical
Figure 3 54: Class 2 Device Recall Intuitive Surgical
Figure 3 55: Class 2 Device Recall Intuitive Surgical
Figure 3 56: Class 2 Device Recall Intuitive Surgical
Figure 3 57: Class 2 Device Recall Intuitive Surgical
Figure 3 58: Class 2 Device Recall Intuitive Surgical
Figure 3 59: Class 2 Device Recall Intuitive Surgical
Figure 3 60: Class 2 Device Recall Intuitive Surgical
Figure 3 61: Class 2 Device Recall Intuitive Surgical
Figure 3 62: Class 2 Device Recall Intuitive Surgical
Figure 3 63: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 64: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 65: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 66: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 67: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 68: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 69: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 70: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 71: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 72: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 73: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 74: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer
Figure 3 75: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer
Figure 3 76: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors
Figure 3 77: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients
Figure 3 78: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors
Figure 3 79: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer
Figure 3 80: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
Figure 3 81: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI)
Figure 3 82: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy
Figure 3 83: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Figure 3 84: Stereotactic Radiosurgery for Soft Tissue Sarcoma
Figure 3 85: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Figure 3 86: Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System
Figure 3 87: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus
Figure 3 88: Manual vs Amigo SmartTouch Atrial Fibrillation Study (MAST-AF)
Figure 3 89: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)
Figure 3 90: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)
Figure 3 91: Post-Market CorPath Registry on the CorPath 200 System
Figure 3 92: Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System
Figure 3 93: Registry of the Magellan Robotic System (ROVER)
Figure 3 94: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
Figure 3 95: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System
Figure 3 96: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci
Figure 3 97: Robotic-assisted Versus Laparoscopic Sigmoid Resection
Figure 3 98: Prospective Investigation of Robotic Single-port System
Figure 3 99: Clinical Outcomes of Knee Replacement
Figure 3 100: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot
Figure 3 101: Robotic Arm Assisted Total Knee Arthroplasty
Figure 3 102: Outcomes of Robotic Total Hip Arthroplasty
Figure 3 103: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement
Figure 3 104: Prospective, Observational Registry of Renaissance-guided Spine Surgeries
Figure 3 105: Clinical Trial of Minimally Invasive Robotic Spine Surgery
Figure 3 106: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI)
Figure 3 107: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
Figure 3 108: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries
Figure 3 109: A Post-Market Clinical Trial for Access and Visualization
Figure 3 110: Robotic-assisted Pedicule Screw Placement (ARASS)
Figure 4 1: Spine Robotic Assisted Surgery System Market, Europe, 2013 – 2023 (€)
Figure 4 2: Units Sold by Country, Spine Robotic Assisted Surgery System, Europe, 2013 – 2023
Figure 4 3: ASP by Country, Spine Robotic Assisted Surgery System, Europe, 2013 – 2023 (€)
Figure 4 4: ASP by Country, Spine Robotic Assisted Surgery System, Europe, 2013 – 2023 (US$)
Figure 4 5: Market Value by Country, Spine Robotic Assisted Surgery System, Europe, 2013 – 2023 (€M)
Figure 4 6: Market Value by Country, Spine Robotic Assisted Surgery System, Europe, 2013 – 2023 (US$M)
Figure 4 7: Drivers and Limiters, Spine Robotic Assisted Surgery System Market, Europe, 2016
Figure 4 8: Leading Competitors, Spine Robotic Assisted Surgery System Market, Europe, 2016
Figure 4 9: Neurosurgery Robotic Assisted Surgery System Market, Europe, 2013 – 2023 (€)
Figure 4 10: Units Sold by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 – 2023
Figure 4 11: ASP by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 – 2023 (€)
Figure 4 12: ASP by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 – 2023 (US$)
Figure 4 13: Market Value by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 – 2023 (€M)
Figure 4 14: Market Value by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 – 2023 (US$M)
Figure 4 15: Drivers and Limiters, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
Figure 4 16: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
Figure 4 17: Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023 (€)
Figure 4 18: Units Sold by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023
Figure 4 19: ASP by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023 (€)
Figure 4 20: ASP by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023 (US$)
Figure 4 21: Market Value by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023 (€M)
Figure 4 22: Market Value by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 – 2023 (US$M)
Figure 4 23: Drivers and Limiters, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
Figure 4 24: Leading Competitors by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
Figure 4 25: Robotic Radiosurgery Device Market, Europe, 2013 – 2023
Figure 4 26: Units Sold by Country, Robotic Radiosurgery Device Market, Europe, 2013 – 2023
Figure 4 27: ASP by Country, Robotic Radiosurgery Device Market, Europe, 2013 – 2023 (€)
Figure 4 28: ASP by Country, Robotic Radiosurgery Device Market, Europe, 2013 – 2023 (US$)
Figure 4 29: Market Value by Country, Robotic Radiosurgery Device Market, Europe, 2013 – 2023 (€M)
Figure 4 30: Market Value by Country, Robotic Radiosurgery Device Market, Europe, 2013 – 2023 (US$M)
Figure 4 31: Drivers and Limiters, Robotic Radiosurgery Device Market, Europe, 2016
Figure 4 32: Leading Competitors, Robotic Radiosurgery Device Market, Europe, 2016
Figure 4 33: Robotic Catheter System Market, Europe, 2013 – 2023
Figure 4 34: Units Sold by Country, Robotic Catheter System Market, Europe, 2013 – 2023
Figure 4 35: ASP by Country, Robotic Catheter System Market, Europe, 2013 – 2023 (€)
Figure 4 36: ASP by Country, Robotic Catheter System Market, Europe, 2013 – 2023 (US$)
Figure 4 37: Market Value by Country, Robotic Catheter System Market, Europe, 2013 – 2023 (€M)
Figure 4 38: Market Value by Country, Robotic Catheter System Market, Europe, 2013 – 2023 (US$M)
Figure 4 39: Drivers and Limiters, Robotic Catheter System Market, Europe, 2016
Figure 4 40: Leading Competitors, Robotic Catheter System Market, Europe, 2016
Figure 4 41: Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023
Figure 4 42: Units Sold by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023
Figure 4 43: ASP by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023 (€)
Figure 4 44: ASP by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023 (US$)
Figure 4 45: Market Value by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023 (€M)
Figure 4 46: Market Value by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 – 2023 (US$M)
Figure 4 47: Drivers and Limiters, Robotic Assisted Orthopedic Surgery Market, Europe, 2016
Figure 4 48: Leading Competitors by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2016
Figure 6 1: Robotic Assisted Surgery Press Release Summary
Figure 6 2: Surgical Navigation Press Release Summary

Europe Market Report for Surgical Robotics Systems 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Minimally invasive surgery (MIS) has become a priority in most surgical disciplines including spinal surgery. The natural evolution of equipment has yielded robotic assisted surgery platforms which provide MIS. However, robotic spine surgery is still very new; it is less than ten years old. In the European market, there are currently only two systems that have been approved. The technology benefits the surgeon by allowing for smaller incisions, MIS, and the technology which guides the surgeon. The main goal is to decrease hospital stay, decrease healing time and improve the surgery experience. Due to the infancy of the market, the future is unknown; however, short term studies have demonstrated clear benefits of using robotic systems for spine surgery.

Surgical robotics has tremendous potential to increase the effectiveness of existing procedures and to facilitate novel procedure types. The surgical robotics industry is, in many ways, still in its infancy, with more products in development than currently commercially available on the market. Early surgical robotics systems were based on industrial robots; however, most new surgical robotic systems are designed for highly specialized medical applications, which is a major drawback for most facilities.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;